mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-09 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
3e-09 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-09 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
6e-09 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-09 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-09 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-09 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-09 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-08 |